This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,620.35 contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to reverse opioid overdoses. The contract has an ultimate completion date of January 20, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $9,980.96, is for the delivery of NARCAN 4 MG NASAL 2S, a critical medication used for the emergency treatment of opioid overdose. This contract is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,195.53, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), which has a ceiling value of $999,999,999 and runs through November 2026. The contract is for the supply of NARCAN 4 MG NASAL 2S, a critical medical product used for the treatment of opioid overdose. The...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,145.58 delivery order contract is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication. The contract has a firm fixed price pricing type and an ultimate completion date of August 14, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a larger...
This federal contract award, valued at $2,005.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a product used to reverse opioid overdose. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 23, 2025. This award is not associated with a set-aside program and is open to full and open...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at up to $57,751.10, is for the delivery of NARCAN 4MG NASAL 2S, a medication used to reverse opioid overdose. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of October 19, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award is a delivery order (SPE2DB23FP76X) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used for opioid overdose reversal. The contract has a firm fixed price of $8,758.69 and a completion date of August 21, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
This federal contract award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication, to the Defense Logistics Agency (DLA). The $1,459.58 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on April 30, 2024, with a completion date of May 1, 2024. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with...
This federal contract award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses, to the Defense Logistics Agency (DLA). The $10,397.54 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with no set-aside designation. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the...
This federal contract award, valued at $17,982.89, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used for opioid overdose reversal. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC...